197 related articles for article (PubMed ID: 33116664)
1. Rifampicin-Resistant
Araya S; Negesso AE; Tamir Z
Infect Drug Resist; 2020; 13():3451-3459. PubMed ID: 33116664
[TBL] [Abstract][Full Text] [Related]
2. Detection of
Diriba G; Alemu A; Tola HH; Eshetu K; Yenew B; Amare M; Dagne B; Mollalign H; Sinshaw W; Abebaw Y; Seid G; Tadesse M; Zerihun B; Getu M; Moga S; Meaza A; Gamtesa DF; Tefera Z; Wondimu A; Hailu M; Buta B; Getahun M; Kebede A
IJID Reg; 2022 Dec; 5():97-103. PubMed ID: 36247095
[TBL] [Abstract][Full Text] [Related]
3. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
Wasihun AG; Dejene TA; Hailu GG
PLoS One; 2020; 15(11):e0240361. PubMed ID: 33147218
[TBL] [Abstract][Full Text] [Related]
4. Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021.
Biset S; Teferi M; Alamirew H; Birhanu B; Dessie A; Aschale A; Haymanot A; Dejenie S; Gebremedhin T; Abebe W; Adane G
BMC Infect Dis; 2024 Feb; 24(1):238. PubMed ID: 38389060
[TBL] [Abstract][Full Text] [Related]
5. High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia.
Akalu GT; Tessema B; Petros B
PLoS One; 2022; 17(12):e0277145. PubMed ID: 36584037
[TBL] [Abstract][Full Text] [Related]
6. The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia.
Diriba K; Awulachew E; Churiso G
Infect Drug Resist; 2021; 14():3961-3969. PubMed ID: 34594119
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia.
Arega B; Menbere F; Getachew Y
BMC Infect Dis; 2019 Apr; 19(1):307. PubMed ID: 30947695
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015-2019.
Wasihun AG; Hailu GG; Dejene TA
Infect Dis Ther; 2021 Sep; 10(3):1299-1308. PubMed ID: 33950463
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
[TBL] [Abstract][Full Text] [Related]
10. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of
Demissie TA; Belayneh D
Infect Drug Resist; 2021; 14():1335-1341. PubMed ID: 33854346
[TBL] [Abstract][Full Text] [Related]
12. Magnitude of Mycobacterium tuberculosis, drug resistance and associated factors among presumptive tuberculosis patients at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Kassa M; Desta K; Ambachew R; Gebreyohannes Z; Gebreyohanns A; Zena N; Amare M; Zerihun B; Getu M; Gize A
PLoS One; 2022; 17(8):e0272459. PubMed ID: 35913968
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary tuberculosis and multidrug-resistant
Wubu B; Jemal M; Million Y; Gizachew M
Front Med (Lausanne); 2023; 10():1266780. PubMed ID: 38152299
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Tuberculosis and Rifampicin Resistant Mycobacterium Tuberculosis in Children and Adolescents using Gene Xpert MTB/RIF Assay in Tigray, Northern Ethiopia.
Dejene TA; Hailu GG; Kahsay AG; Wasihun AG
Infect Drug Resist; 2023; 16():6757-6765. PubMed ID: 37876859
[TBL] [Abstract][Full Text] [Related]
15. Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia.
Admassu W; Ayelign B; Abebe G; Tadesse M
PLoS One; 2022; 17(1):e0262929. PubMed ID: 35085337
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of active tuberculosis and associated factors among people with chronic psychotic disorders at St. Amanuel Mental Specialized Hospital and Gergesenon Mental Rehabilitation center, Addis Ababa, Ethiopia.
Temesgen E; Belete Y; Haile K; Ali S
BMC Infect Dis; 2021 Oct; 21(1):1100. PubMed ID: 34702208
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin-resistant
Jaleta KN; Gizachew M; Gelaw B; Tesfa H; Getaneh A; Biadgo B
Infect Drug Resist; 2017; 10():185-192. PubMed ID: 28652786
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Diriba G; Kebede A; Tola HH; Yenew B; Moga S; Addise D; Alemu A; Mohammed Z; Getahun M; Fantahun M; Tadesse M; Dagne B; Amare M; Assefa G; Abera D; Desta K
PLoS One; 2020; 15(12):e0243493. PubMed ID: 33284842
[TBL] [Abstract][Full Text] [Related]
19. Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia.
Alemu A; Tadesse M; Seid G; Mollalign H; Eshetu K; Sinshaw W; Abebaw Y; Amare M; Dagne B; Diriba G; Yenew B; Getu M; Zerihun B
BMC Infect Dis; 2020 Jan; 20(1):87. PubMed ID: 32000702
[TBL] [Abstract][Full Text] [Related]
20. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
